University of Michigan Cancer Center [clinicaltrials_resource:f00d1c86a0b7ccc0475aa3303e207e9a]
Mark Kaminski, M.D. [clinicaltrials_resource:03948c3d3da2e25cbabfaf01cd5d3a3b]Daniel Couriel [clinicaltrials_resource:04a79a7a6a03ac52e80501d761174b44]Antonio Pellicer, MDPhD [clinicaltrials_resource:04d4442faff5f7e35e194ccdd801cc11]Ryan Wilcox, M.D., Ph.D. [clinicaltrials_resource:05eebb83aaff19c152f9fa14ca567f5b]Pavan Reddy, MD [clinicaltrials_resource:066af987c0681ccd090e5e785b1deb17]Daniel F Hayes, M.D. [clinicaltrials_resource:09d87c827ab722f7c0aaa2b8e26ca540]Andrzej J. Jakubowiak, MD, PhD [clinicaltrials_resource:0c8f2079fe8ff166066fd8dba1fa901d]Daniel F Hayes, M.D. [clinicaltrials_resource:0ea5a265d3409b31aa9d21e610862d8e]Frank Worden, MD [clinicaltrials_resource:0ecaef117ce901ec056a84060b9f7515]Theodore Lawrence, M.D., Ph.D. [clinicaltrials_resource:10c2600f45e5d1b24a3f185883237c9c]Pavan Reddy, MD [clinicaltrials_resource:10db263b2784d9dbb6f0c398e02323c2]James Hayman, M.D. [clinicaltrials_resource:10f0115f18cdeea9ed79dc2737e14cc8]sami Malek, MD [clinicaltrials_resource:1145e2a9ade2b99f480aa2414523e57e]Anne F. Schott, M.D. [clinicaltrials_resource:14a3a830cd4f0a46aceab0c6a0c5f3ae]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Laurence H. Baker, DO, FACOI [clinicaltrials_resource:1528d7fa0b670ffb2717f638da3e522d]Jeffrey Smerage, M.D., Ph.D. [clinicaltrials_resource:1618cae7fb57b7356d23091ac8330ad7]sami Malek, MD [clinicaltrials_resource:16e91992e693f9231275534098c8d5dd]Lisa Newman, M.D. [clinicaltrials_resource:191fbd7b028d6c5452a69a7c86def834]Daniel F. Hayes, MD [clinicaltrials_resource:1a83bf0ec5596d62dbda6dc0b9e372a5]Felix Feng, M.D. [clinicaltrials_resource:1b02f1c4ed9e794e1f7086854767eff7]Daniel A. Hamstra, M.D., Ph.D. [clinicaltrials_resource:1b6313d5ecea51e1fc73f6460c364168]Attaphol Pawarode, M.D. [clinicaltrials_resource:1c6ddcdda76c1b0877adde19233a3b5c]Maha Hussain, M.D.(M.B., Ch.B.) [clinicaltrials_resource:1d4b8bec54ea689b9af10159b2004715]John M Magenau, M.D. [clinicaltrials_resource:1d4c2bc8c1bdaed82a2b147db7c25173]Avraham Eisbruch, MD [clinicaltrials_resource:1f1011b6da49819e73f9de2dc4bcc8fd]Norah L Henry, MD, PhD [clinicaltrials_resource:1fa21db15e079efd1f3a380ab657430e]Felix Feng, M.D. [clinicaltrials_resource:20fa614cf1688298bf71313b2583c05f]BioMed Valley Discoveries Inc [clinicaltrials_resource:22c6c662e075e9008ed7550f28155065]Daniel M Couriel, MD [clinicaltrials_resource:2697f684d767334e4311a32350232a26]Sarah T. Hawley, PhD, MPH [clinicaltrials_resource:27a9bbff30d1f732e021ec1ffae0201a]Mary Feng, M.D. [clinicaltrials_resource:27f626b772a814e58e720166e10c1a7f]Theodore Lawrence, M.D., Ph.D. [clinicaltrials_resource:29172094dd9a614c191c94eb2a5e9d24]Mary Feng, MD [clinicaltrials_resource:2bd5c9e445a10efe4a9c16d2ef60ddd4]Shruti Jolly, MD [clinicaltrials_resource:2e2e7021ebe9d1a7b7453b15f7c720f5]Dean E. Brenner, MD [clinicaltrials_resource:30062eb124ac65ac8e74f45327f1f83d]sami Malek, MD [clinicaltrials_resource:30f908c66c01e123fac7160b0887de43]Nithya Ramnath, M.D. [clinicaltrials_resource:345ad5649956e0ae096531c5c02c9167]Shruti Jolly, M.D. [clinicaltrials_resource:3490a98996fd0702d57875db49cf8cec]Avraham Eisbruch, MD [clinicaltrials_resource:34db580fa308a91b260542237b69dd30]
affiliation [clinicaltrials_vocabulary:affiliation]
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus [clinicaltrials:NCT00003076]UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia [clinicaltrials:NCT00003598]Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00005598]Curcumin for the Prevention of Colon Cancer [clinicaltrials:NCT00027495]UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer [clinicaltrials:NCT00064272]Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer [clinicaltrials:NCT00134355]clinicaltrials:NCT00135200UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer [clinicaltrials:NCT00146042]Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer [clinicaltrials:NCT00148070]clinicaltrials:NCT00148109Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site [clinicaltrials:NCT00148135]Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer [clinicaltrials:NCT00151034]clinicaltrials:NCT00151073Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer [clinicaltrials:NCT00151086]Treatment for Patients With Metastatic Thyroid Cancer [clinicaltrials:NCT00176748]Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine [clinicaltrials:NCT00176761]Radiation Therapy With Capecitabine in Rectal Cancer [clinicaltrials:NCT00176787]Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer [clinicaltrials:NCT00176813]Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer [clinicaltrials:NCT00242190]clinicaltrials:NCT00393796A Pilot Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer [clinicaltrials:NCT00399321]clinicaltrials:NCT00456599clinicaltrials:NCT00480857clinicaltrials:NCT00556452clinicaltrials:NCT00570531clinicaltrials:NCT00585689clinicaltrials:NCT00593866clinicaltrials:NCT00615589clinicaltrials:NCT00639717clinicaltrials:NCT00644696clinicaltrials:NCT00645333clinicaltrials:NCT00645593clinicaltrials:NCT00763490UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer [clinicaltrials:NCT00900094]Computer-Based Tailored or Standard Information for Colorectal Cancer Screening [clinicaltrials:NCT00955188]Tamoxifen Citrate Decision Aids for Women at Increased Risk of Breast Cancer [clinicaltrials:NCT00967824]clinicaltrials:NCT00995488clinicaltrials:NCT01028352clinicaltrials:NCT01029054clinicaltrials:NCT01188889
collaborator [clinicaltrials_vocabulary:collaborator]
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus [clinicaltrials:NCT00003076]UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia [clinicaltrials:NCT00003598]Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00005598]Curcumin for the Prevention of Colon Cancer [clinicaltrials:NCT00027495]UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer [clinicaltrials:NCT00064272]clinicaltrials:NCT00115739Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma [clinicaltrials:NCT00116961]Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer [clinicaltrials:NCT00134355]Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma [clinicaltrials:NCT00135187]clinicaltrials:NCT00135200Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder [clinicaltrials:NCT00136175]Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma [clinicaltrials:NCT00141700]The Use of Etanercept (EnbrelĀ®) in the Treatment of Acute Graft-Versus-Host Disease [clinicaltrials:NCT00141713]clinicaltrials:NCT00141726clinicaltrials:NCT00141739clinicaltrials:NCT00141765clinicaltrials:NCT00143845Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma [clinicaltrials:NCT00143871]Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood [clinicaltrials:NCT00143884]Companion Pharmacogenetic Study to UMCC 9900/9901 [clinicaltrials:NCT00146029]UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer [clinicaltrials:NCT00146042]Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood [clinicaltrials:NCT00146055]Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer [clinicaltrials:NCT00148070]clinicaltrials:NCT00148109clinicaltrials:NCT00148122Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site [clinicaltrials:NCT00148135]Tetrathiomolybdate in Hormone Refractory Prostate Cancer [clinicaltrials:NCT00150995]Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer [clinicaltrials:NCT00151034]Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer [clinicaltrials:NCT00151047]Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate [clinicaltrials:NCT00151060]clinicaltrials:NCT00151073Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer [clinicaltrials:NCT00151086]Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage [clinicaltrials:NCT00156260]Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer [clinicaltrials:NCT00156273]Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC [clinicaltrials:NCT00156286]Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine [clinicaltrials:NCT00156312]Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer [clinicaltrials:NCT00161265]Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling [clinicaltrials:NCT00161278]Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer [clinicaltrials:NCT00176735]Treatment for Patients With Metastatic Thyroid Cancer [clinicaltrials:NCT00176748]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus [clinicaltrials:NCT00003076]UMCC 9609 Tretinoin in Preventing Cancer of the Cervix in Patients With Cervical Neoplasia [clinicaltrials:NCT00003598]Azacitidine Plus Amifostine in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00005598]Curcumin for the Prevention of Colon Cancer [clinicaltrials:NCT00027495]UMCCOP 02-01 Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer [clinicaltrials:NCT00064272]clinicaltrials:NCT00115739Velcade, Doxil, and Dexamethasone (VDd) as First Line Therapy for Multiple Myeloma [clinicaltrials:NCT00116961]Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer [clinicaltrials:NCT00134355]Study of Combination Therapy With VELCADE, Doxil, and Dexamethasone (VDd) in Multiple Myeloma [clinicaltrials:NCT00135187]clinicaltrials:NCT00135200Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder [clinicaltrials:NCT00136175]Study of Rituximab Plus High-Dose Chemotherapy Poor Prognosis Non-Hodgkin's Lymphoma [clinicaltrials:NCT00141700]The Use of Etanercept (EnbrelĀ®) in the Treatment of Acute Graft-Versus-Host Disease [clinicaltrials:NCT00141713]clinicaltrials:NCT00141726clinicaltrials:NCT00141739clinicaltrials:NCT00141765clinicaltrials:NCT00143845Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma [clinicaltrials:NCT00143871]Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood [clinicaltrials:NCT00143884]Companion Pharmacogenetic Study to UMCC 9900/9901 [clinicaltrials:NCT00146029]UMCC 9901: Phase II Study of Tailored-Dose Docetaxel + Trastuzumab in Her-2 Positive Metastatic Breast Cancer [clinicaltrials:NCT00146042]Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood [clinicaltrials:NCT00146055]Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer [clinicaltrials:NCT00148070]clinicaltrials:NCT00148109clinicaltrials:NCT00148122Combination of Carboplatin, Gemcitabine, and Capecitabine in Patients With Carcinoma of Unknown Primary Site [clinicaltrials:NCT00148135]Tetrathiomolybdate in Hormone Refractory Prostate Cancer [clinicaltrials:NCT00150995]Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer [clinicaltrials:NCT00151034]Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer [clinicaltrials:NCT00151047]Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate [clinicaltrials:NCT00151060]clinicaltrials:NCT00151073Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer [clinicaltrials:NCT00151086]Feasibility Study of Evaluating Breast Cancer Patients With Ductal Lavage [clinicaltrials:NCT00156260]Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer [clinicaltrials:NCT00156273]Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC [clinicaltrials:NCT00156286]Evaluation of Tumor Factors in Breast Cancer Treated With Docetaxel and Capecitabine [clinicaltrials:NCT00156312]Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer [clinicaltrials:NCT00161265]Pilot Study for the Determination of Tumor Response to Chemotherapy in Advanced NSCLC Through Gene Expression Profiling [clinicaltrials:NCT00161278]Capecitabine and Radiation Therapy in Advanced Pancreatic Cancer [clinicaltrials:NCT00176735]Treatment for Patients With Metastatic Thyroid Cancer [clinicaltrials:NCT00176748]
source [clinicaltrials_vocabulary:source]
University of Michigan Cancer Center [clinicaltrials_resource:f00d1c86a0b7ccc0475aa3303e207e9a]
Bio2RDF identifier
f00d1c86a0b7ccc0475aa3303e207e9a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:f00d1c86a0b7ccc0475aa3303e207e9a
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:f00d1c86a0b7ccc0475aa3303e207e9a
title
University of Michigan Cancer Center
@en
type
label
University of Michigan Cancer ...... d1c86a0b7ccc0475aa3303e207e9a]
@en